Jones Woody Bryan
President chez Revolo Biotherapeutics Ltd.
Profil
Jones Woody Bryan is currently the Director at Afecta Pharmaceuticals, Inc. and a Member of the Licensing Executives Society.
Additionally, he is the President & Chief Business Officer at Revolo Biotherapeutics Ltd.
since 2022.
Previously, Dr. Bryan served as the Chairman at Arthur M Spiro Institute For Entrepreneurial Leadership.
He also held the position of Director-Business Development at AAI Corp.
and Senior Vice President-Business Development at Sucampo Pharmaceuticals, Inc. From 2010 to 2015, he was the Vice President-Business Development at Supernus Pharmaceuticals, Inc. and from 2000 to 2007, he held the same position at Shire Laboratories, Inc. He also served as the Senior Vice President-Business Development at Lupin Pharmaceuticals, Inc. and UroGen Pharma Ltd.
from 2018 to 2020.
Dr. Bryan obtained a doctorate degree from the Medical University of South Carolina and an undergraduate degree from Clemson University.
Postes actifs de Jones Woody Bryan
Sociétés | Poste | Début |
---|---|---|
Licensing Executives Society | Corporate Officer/Principal | 29/12/2010 |
Afecta Pharmaceuticals, Inc.
Afecta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afecta Pharmaceuticals, Inc. is a private company based in Irvine, CA. | Directeur/Membre du Conseil | - |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | President | 01/06/2022 |
Anciens postes connus de Jones Woody Bryan
Sociétés | Poste | Fin |
---|---|---|
UROGEN PHARMA LTD. | Corporate Officer/Principal | 01/07/2020 |
SUPERNUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09/04/2015 |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Corporate Officer/Principal | 12/10/2007 |
Arthur M Spiro Institute For Entrepreneurial Leadrship | Président | - |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lupin Pharmaceuticals, Inc. provides pharmaceutical products healthcare professionals and patients across geographies. The firm offers generic, specialty and active pharmaceutical ingredient drugs for diabetic, anti-inflammatory and respiratory therapy. The company was founded in 2003 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | - |
Formation de Jones Woody Bryan
Medical University of South Carolina | Doctorate Degree |
Clemson University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
Entreprise privées | 7 |
---|---|
AAI Corp.
AAI Corp. Information Technology ServicesTechnology Services AAI Corp. develops unmanned aircraft systems for training and simulation activities. It offers include unmanned systems, test systems, training systems, logistics and technical services, and advanced systems. The company was founded in 1950 and is headquartered in Hunt Valley, MD. | Technology Services |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Commercial Services |
Licensing Executives Society | |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lupin Pharmaceuticals, Inc. provides pharmaceutical products healthcare professionals and patients across geographies. The firm offers generic, specialty and active pharmaceutical ingredient drugs for diabetic, anti-inflammatory and respiratory therapy. The company was founded in 2003 and is headquartered in Baltimore, MD. | Health Technology |
Afecta Pharmaceuticals, Inc.
Afecta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afecta Pharmaceuticals, Inc. is a private company based in Irvine, CA. | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |